MedPath

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

Phase 2
Recruiting
Conditions
Primary Myelofibrosis (PMF)
Post-Polycythemia Vera MF (Post-PV-MF)
Post-Essential Thrombocythemia MF (Post-ET-MF)
Interventions
Drug: Best Available Therapy (BAT)
Registration Number
NCT03662126
Lead Sponsor
Kartos Therapeutics, Inc.
Brief Summary

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK inhibitor. Inhibition of MDM2 is a novel mechanism of action in MF.

This study will be conducted in 2 phases. Phase 2 will determine the KRT-232 recommended dose and dosing schedule; Phase 3 will test KRT-232 vs Best Available Therapy (BAT). Patients in the Phase 3 part of the study will be randomized 2:1 to receive either KRT-232 (Arm 1) or BAT (Arm 2). The BAT administered will be determined by the treating physician, with the option to "cross-over" to KRT-232 treatment after 6 months of BAT or if the disease worsens at any time.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
385
Inclusion Criteria
  • Confirmed diagnosis of PMF, post-PV MF or post-ET MF (WHO)
  • High, intermediate-2, or intermediate-1 risk Dynamic International Prognostic System (DIPSS)
  • Failure of prior treatment with JAK inhibitor
  • ECOG ≤ 2
Exclusion Criteria
  • Prior splenectomy
  • Splenic irradiation within 3 months prior to randomization
  • History of major hemorrhage or intracranial hemorrhage within 6 months prior to randomization
  • History of stroke, reversible ischemic neurological defect or transient ischemic attack within 6 months prior to randomization
  • Prior MDM2 inhibitor therapy or p53-directed therapy
  • Prior allogeneic stem-cell transplant or plans for allogeneic stem cell transplant
  • History of major organ transplant
  • Grade 2 or higher QTc prolongation (> 480 milliseconds per NCI-CTCAE criteria, version 5.0)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Part A Cohort 3KRT-232KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-28 (28-day cycles)
Part A Cohort 4bKRT-232KRT-232 240 mg by mouth once daily for Days 1-5, off treatment for Days 6-28 (28-day cycles)
Part B Arm 1 KRT-232KRT-232KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-28 (28-day cycles)
Part B Arm 2 Best Available TherapyBest Available Therapy (BAT)Best available therapy at the discretion of the investigator, on a 28-day cycle.
Part A Cohort 1KRT-232KRT-232 120 mg by mouth once daily for Days 1-7, off treatment for Days 8-21 (21-day cycles)
Part A Cohort 2KRT-232KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-21 (21-day cycles)
Primary Outcome Measures
NameTimeMethod
(Part A Only) Spleen Volume Reduction (SVR)24 weeks

The proportion of subjects achieving a ≥ 35% spleen volume reduction (SVR) from Baseline to Week 24, as assessed by magnetic resonance imaging (MRI) or computed tomography (CT) scan

(Part B Only) Spleen Volume Reduction (SVR)24 Weeks

The proportion of subjects achieving SVR of ≥ 35% at Week 24 by MRI/CT scan (central review)

Secondary Outcome Measures
NameTimeMethod
(Part A only) Improvement in Total Symptom Score (TSS)48 weeks

The proportion of subjects who have at least a 50% reduction from Baseline to Week 24 and Week 48 in the total symptom score as measured by the modified MPN-SAF v2.0

(Part B only) Improvement of Total Symptom Score (TSS)24 Weeks

The proportion of subjects who have at least a 50% reduction from Baseline to Week 24 in the total symptom score as measured by the MF-SAF v4.0

(Part B Only) Overall Spleen Volume Reduction (SVR)48 months

The proportion of subjects in each arm achieving SVR of ≥ 35% at any time by MRI/CT scan (central review)

(Part B only) Overall Survival (OS)48 months

Time from randomization to death from any cause

(Part B only) Progression free survival (PFS)48 months

Time from randomization to either first occurrence of disease progression or death due to any cause

(Part B Only) Spleen Response Duration48 months

Time from initial SVR of ≥ 35% by MRI/CT (central review) until the first occurrence of disease progression

(Part B Only) Rate of conversion from RBC transfusion dependent to independent24 weeks

The proportion of subjects who have RBC transfusion independence at week 24

Trial Locations

Locations (191)

University Campus of Patras - Hematology

🇬🇷

Patras, Greece

University General Hospital of Ioannina

🇬🇷

Ioánnina, Ioannina, Greece

Sanatorio de la Mujer

🇦🇷

Rosario, Santa Fe, Argentina

UNICAMP - Universidade Estadual de Campinas Hemocentro

🇧🇷

Campinas, São Paulo, Brazil

South Eastern Private Hospital

🇦🇺

Noble Park, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, Australia

Centro Medico San Luis

🇦🇷

Caba, Argentina

Icon Cancer Center

🇦🇺

South Brisbane, Australia

Centro de oncologia Leonardo da Vinci

🇧🇷

Fortaleza, Ceara, Brazil

Clinical Hospital Centre Osijek

🇭🇷

Zagreb, Croatia

Vseonecma fakultni nemocrince V Praze

🇨🇿

Nové Město, Czechia

Fakultní Nemocnice Olomouc

🇨🇿

Olomouc, Czechia

University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski, Pleven

🇧🇬

Pleven, Bulgaria

Hospital de Clinicas de Porto Alegre - Centro de Pesquisa Clinica

🇧🇷

Porto Alegre, Brazil

Fundacao Doutor Amaral Carvalho

🇧🇷

Jau, Brazil

Centre Hospitalier Universitaire D'Amiens (Hopital Sud) - Hématologie Clinique

🇫🇷

Amiens, France

Monash Medical Centre

🇦🇺

Clayton, Victoria, Australia

AO Spedali Civili di Brescia

🇮🇹

Brescia, Italy

Prince of Wales Hospital - Medicine

🇭🇰

Shatin, Hong Kong

AHEPA General Hospital of Thessaloniki

🇬🇷

Thessaloníki, Greece

Stauferklinikum Schwäbisch Gmünd

🇩🇪

Mutlangen, Germany

Praxis für Hämatologie und Onkologie

🇩🇪

Saarbrücken, Germany

Hospital das Clínicas UFG

🇧🇷

Goiânia, Brazil

Centre Hospitalier Universitaire de Nîmes

🇫🇷

Nîmes, France

Markusovszky Egyetemi Oktatókórház

🇭🇺

Szombathely, Vas, Hungary

Centre Hospitalier Universitaire of Caen Normandie - Côte de Nacre

🇫🇷

Caen, France

Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház

🇭🇺

Nyíregyháza, Szabolcs-Szatmar-Bereg, Hungary

Acibadem City Clinic Tokuda Hospital, Sofia

🇧🇬

Sofia, Bulgaria

FN Hradec Kralove

🇨🇿

Králová, Czechia

Specialized Hospital for Active Therapy of Hematological Disorders

🇧🇬

Sofia, Bulgaria

A.O.di Bologna Policl.S.Orsola

🇮🇹

Bologna, Italy

Szegedi Tudományegyetem

🇭🇺

Szeged, Hungary

Rambam Medical Centre

🇮🇱

Haifa, Israel

Universitätsmedizin der Johannes Gutenberg Universität Mainz

🇩🇪

Mainz, Germany

C.H de la Côte Basque - Serviv

🇫🇷

Bayonne, France

Gemeinschaftspraxis Haematologie - Onkologie - Hauptstelle

🇩🇪

Dresden, Sachsen, Germany

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

Universitätsklinikum Aachen

🇩🇪

Aachen, Nordrhein-Westfalen, Germany

Klinikum Rechts der Isar der Technischen Universität München Apotheke

🇩🇪

München, Bayern, Germany

Hôpital Saint-Louis

🇫🇷

Paris, France

PO Civile SS.Antonio e Biagio

🇮🇹

Alessandria, Italy

Universitätsklinikum Halle

🇩🇪

Halle, Sachsen-Anhalt, Germany

Assaf Harofeh Medical Center - Hematology

🇮🇱

Zerifin, Israel

Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum

🇭🇺

Debrecen, Hungary

Semmelweis Egyetem

🇭🇺

Budapest, Hungary

Hospital of Lithuanian University of Health Sciences Kaunas

🇱🇹

Kaunas, Lithuania

Oaxaca Site Management Organization OSMO

🇲🇽

Oaxaca, Mexico

Sociedad de Metabolismo y Corazón S.C. - Oncology

🇲🇽

Veracruz, Mexico

Spitalul Clinic Colentina

🇷🇴

Bucharest, Romania

Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza

🇵🇱

Brzozow, Podkarpackie, Poland

Szpital Wojewódzki w Opolu

🇵🇱

Opole, Poland

Western Galilee Hospital - Nahariya

🇮🇱

Nahariya, Israel

Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet

🇭🇺

Budapest, Hungary

Hospital de Braga

🇵🇹

Braga, Portugal

Champalimaud Cancer Center

🇵🇹

Lisbon, Portugal

Spitalul Clinic Municipal Filantropia Craiova

🇷🇴

Craiova, Romania

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie

🇵🇱

Lublin, Poland

SPZOZ MSWiA z Warminsko - Mazurskim Centrum Onkologii

🇵🇱

Olsztyn, Poland

The Catholic University of Korea, Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Yeungnam University Medical Center

🇰🇷

Daegu, Korea, Republic of

Tel Aviv Sourasky Medical Center - Oncology

🇮🇱

Tel Aviv, Israel

Rabin Medical Center - Beilinson Hospital

🇮🇱

Petah Tikva, Israel

Hematology Institute

🇮🇱

Kfar Saba, Israel

AOU Ospedali Riuniti Umberto I G.M. Lancisi G. Salesi

🇮🇹

Ancona, Italy

Institutul Oncologic "Prof. Dr. Ion Chiricuta"

🇷🇴

Cluj-Napoca, Romania

Universidad Autonoma de Nuevo Leon (UANL) - Hospital Universitario "Dr. Jose Eleuterio Gonzalez

🇲🇽

Monterrey, Nuevo Leon, Mexico

Perpetual Succour Hospital - Hemat/Transfusion Med

🇵🇭

Cebu City, Philippines

Hadassah Medical Organisation

🇮🇱

Jerusalem, Israel

CHA Bundang Medical Center, CHA University

🇰🇷

Seongnam-si, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

H. São Francisco Xavier-Centro Hospitalar Lisboa Ocidental

🇵🇹

Lisboa, Portugal

Cen Med de Diagn si Trat Amb NEOMED

🇷🇴

Brasov, Romania

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Samodzielny Publiczny Zakład Opieki Zdrowotnej Zespół Szpitali Miejskich

🇵🇱

Chorzów, Slaskie, Poland

Szpital Uniwersytecki nr 2 im dr. Jana Biziela

🇵🇱

Bydgoszcz, Poland

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o.

🇵🇱

Słupsk, Poland

University of the Philippines - Philippine General Hospital

🇵🇭

Manila, Philippines

Instituto Português de Oncologia de Coimbra

🇵🇹

Coimbra, Portugal

Spitalul Clinic Coltea

🇷🇴

Bucuresti, Romania

Institutul Regional de Oncologie Iasi

🇷🇴

Iaşi, Romania

China Medical University Hospital

🇨🇳

Taichung, Taiwan

Dolnośląskie Centrum Transplantacji Komórkowych z Krajowym Bankiem Dawców Szpiku

🇵🇱

Wrocław, Dolnoslaskie, Poland

Inje University Busan Paik Hospital

🇰🇷

Busan, Korea, Republic of

Oncologic dispensary of Komi Republic

🇷🇺

Syktyvkar, Russian Federation

ASST Grande Ospedale Metropolitano Niguarda

🇮🇹

Milano, Italy

Hospital Universitario Puerta de Hierro - Majadahonda

🇪🇸

Majadahonda, Madrid, Spain

Instituto Mexicano del Seguro Social

🇲🇽

Monterrey, Mexico

Clinical Research Center Spółka z Ograniczoną Odpowiedzialnością Medic-R sp. k.

🇵🇱

Poznań, Poland

H. Infante Dom Pedro. Centro Hospitalar do Baixo Vouga

🇵🇹

Aveiro, Portugal

Medicover

🇷🇴

Bucuresti, Romania

Spitalul Clinic Municipal de Urgenta Timisoara

🇷🇴

Timişoara, Romania

Srinagarind Hospital (KhonKaen University)

🇹🇭

Khon Kaen, Thailand

Saint-Petersburg SMU I.P.Pavlov

🇷🇺

St Petersburg, Russian Federation

Clinical oncological dispensary

🇷🇺

Omsk, Russian Federation

Hospital Universitario Virgen de la Victoria

🇪🇸

Málaga, Spain

Oncomed

🇷🇴

Timişoara, Romania

Spitalul Clinic Judetean de Urgenta Tg Mures

🇷🇴

Târgu-Mureş, Romania

Chang Gung Medical Foundation - ChiaYi Chang Gung Memorial Hospital - Chiayi Branch

🇨🇳

Chiayi City, Taiwan

Songklanagarind Hospital

🇹🇭

Songkhla, Thailand

Hospital Universitario de Gran Canaria Doctor Negrin

🇪🇸

Las Palmas De Gran Canaria, Las Palmas, Spain

Hospital de La Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Hospital Universitario Vall d'Hebrón

🇪🇸

Barcelona, Spain

Kaohsiung Medical University - Chung-Ho Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Siriraj Hospital

🇹🇭

Bangkok, Thailand

Pamukkale University

🇹🇷

Denizli, Turkey

Complejo Hospitalario de Navarra - H. de Navarra, Hematología C/ de Irunlarrea, 3, Pamplona

🇪🇸

Pamplona, Spain

National Taiwan University Hospital

🇨🇳

Taipei City, Taipei, Taiwan

Thammasat University Hospital

🇹🇭

Khlong Luang, Thailand

Ondokuz Mayis University Medical Faculty - Hematology

🇹🇷

Samsun, Turkey

Hospital Universitari Germans Trias i Pujol

🇪🇸

Badalona, Barcelona, Spain

Ramathibodi Hospital - Mahidol University - Hematology

🇹🇭

Bangkok, Thailand

Inonu University Turgut Ozal Medical Center

🇹🇷

Malatya, Turkey

NHS Greater Glasgow and Clyde

🇬🇧

Glasgow, United Kingdom

The Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

University of Southern California Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Gabrail Cancer Center

🇺🇸

Canton, Ohio, United States

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

The University of Texas MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

The Kirklin Clinic of UAB Hospital

🇺🇸

Birmingham, Alabama, United States

Northwestern University Feinberg School of Medicine

🇺🇸

Chicago, Illinois, United States

Dana-Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

Fiona Stanley Hosital

🇦🇺

Murdoch, Western Australia, Australia

Princess Margaret Cancer Center

🇨🇦

Toronto, Ontario, Canada

A.O. San Gerardo di Monza - L'Ospedale San Gerardo di Monza e l'Università di Milano

🇮🇹

Monza, Lombardia, Italy

Azienda Ospedaliero Universitaria Policlinico - Vittorio Emanuele

🇮🇹

Catania, Italy

AOU Careggi

🇮🇹

Firenze, Italy

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS

🇮🇹

Meldola, Italy

Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda

🇮🇹

Milano, Italy

AOU Maggiore della Carità

🇮🇹

Novara, Italy

Arcispedale S. Maria Nuova, AO di Reggio Emilia

🇮🇹

Reggio Emilia, Italy

A.O. Citta della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

Sakarya Research and Training Hospital

🇹🇷

Adapazarı, Turkey

Ankara University Faculty of Medicine

🇹🇷

Ankara, Turkey

Gazi University Medical Faculty

🇹🇷

Ankara, Turkey

Gaziantep University Faculty of Medicine

🇹🇷

Gaziantep, Turkey

Mersin University Medical Faculty

🇹🇷

Mersin, Turkey

Centre Hospitalier Regional Universitaire Brest Hopital Morvan

🇫🇷

Brest Cedex, France

Institut Universitaire du Cancer de Toulouse Oncopole

🇫🇷

Toulouse, France

Centre Hospitalier Le Mans

🇫🇷

Le Mans, France

Hopital Paul Brousse - Aphp Hôpitaux Universitaires Paris Su

🇫🇷

Villejuif, France

Guy's and Saint Thomas' NHS Foundation Trust

🇬🇧

London, United Kingdom

University Hospitals Birmingham NHS Foundation Trust

🇬🇧

Birmingham, United Kingdom

Oxford University Hospitals NHS Foundation Trust

🇬🇧

Oxford, United Kingdom

Instituto de Ensino e Pesquisa São Lucas

🇧🇷

Sao Paulo, Brazil

Associação Educadora São Carlos AESC - Hospital Mãe de Deus - Centro de Pesquisa

🇧🇷

Porto Alegre, Brazil

Charité Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

UKE - Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Technische Universität Dresden

🇩🇪

Dresden, Sachsen, Germany

Hospital San Pedro de Alcantara

🇪🇸

Cáceres, Spain

Hospital Universitario Son Espases

🇪🇸

Palma de Mallorca, Spain

Hospital Universitario Doctor Peset

🇪🇸

Valencia, Spain

H. Quirón Zaragoza

🇪🇸

Zaragoza, Spain

Carmel MC

🇮🇱

Haifa, Israel

Hospital Universitario de Salamanca

🇪🇸

Salamanca, Spain

Universitätsklinikum Jena

🇩🇪

Jena, Thuringen, Germany

Innovative Clinical Research Institute

🇺🇸

Whittier, California, United States

Stanford Cancer Center - Palo Alto

🇺🇸

Stanford, California, United States

University Cancer Institute

🇺🇸

Boynton Beach, Florida, United States

Mt. Sinai

🇺🇸

New York, New York, United States

Brookdale University Hospital and Medical Center

🇺🇸

Brooklyn, New York, United States

New York Presbyterian/Weill Cornell Medical Center

🇺🇸

New York, New York, United States

Avera Cancer Institute

🇺🇸

Sioux Falls, South Dakota, United States

Medical College of Wisconsin - Froedtert Hospital

🇺🇸

Milwaukee, Wisconsin, United States

Instituto Medico Alexander Fleming

🇦🇷

Buenos Aires, Argentina

Hospital das Clínicas da Universidade de São Paulo

🇧🇷

Sao Paulo, Brazil

Hospital Privado - Centro Medico de Cordoba - Oncology

🇦🇷

Córdoba, Argentina

Hospital Erasto Gaertner

🇧🇷

Curitiba, Parana, Brazil

The Alfred Hospital

🇦🇺

Melbourne, Australia

Hospital A C Camargo - Fundacao Antonio Prudente

🇧🇷

Sao Paulo, Brazil

Instituto D'or de Pesquisa e Ensino

🇧🇷

São Paulo, Brazil

Instituto COI São Paulo

🇧🇷

São Paulo, Brazil

University Multiprofile Hospital for Active Treatment Sveti Georgi, Plovdiv

🇧🇬

Plovdiv, Bulgaria

Military Medical Academy, Multiprofile for active treatment, Sofia

🇧🇬

Sofia, Bulgaria

University Multiprofile Hospital for Active Treatment Saint Ivan Rilski, Sofia

🇧🇬

Sofia, Bulgaria

University Multiprofile Hospital for Active Treatment Alexandrovska, Sofia

🇧🇬

Sofia, Bulgaria

Center Hospitalier Universitaire d'Angers

🇫🇷

Angers, France

Centre Hospitalier Universitaire de Poitiers

🇫🇷

Poitiers, France

Universitaetsklinikum Essen

🇩🇪

Essen, Nordrhein-Westfalen, Germany

Somogy Megyei Kaposi Mór Oktató Kórház

🇭🇺

Kaposvár, Somogy, Hungary

Ha'Emek Medical Center

🇮🇱

Afula, Israel

Assuta Ashdod University Hospital

🇮🇱

Ashdod, Israel

Assuta MC

🇮🇱

Tel Aviv, Israel

Kyungpook National University Hospital

🇰🇷

Daegu, Korea, Republic of

Azienda Ospedaliera Ospedali Riuniti Marche Nord - Pesaro

🇮🇹

Pesaro, Italy

Policlinico Universitario Agostino Gemelli

🇮🇹

Roma, Italy

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

General Hospital Sibenik

🇭🇷

Sibenik, Croatia

KB Sestre Milosrdnice

🇭🇷

Zagreb, Croatia

© Copyright 2025. All Rights Reserved by MedPath